FinHisaab
Toggle Sidebar
FinHisaab
Search for
/
Command Palette
Search for a command to run...
Portfolio
Watchlist
Markets
More
Toggle Sidebar
FinHisaab
Command Palette
Search for a command to run...
What's New
Home
Portfolio
Watchlist
Calculators
Market
BFBIO Financial Statements – BF Biosciences | FinHisaab
Go Back
Home
Stocks Screener
BF Biosciences Limited
BF Biosciences Limited (BFBIO)
PHARMACEUTICALS
Gold MF Pick
Upside
+35%
ALLSHR
KMIALLSHR
124.18
+0.84%
As of 09-Oct-2026
52 Week Range
Current: 124.18
117.20
177.99
Total Return
Updated: 09-Oct-2026
1M
-1.2%
3M
-10.4%
1Y
-19.9%
3Y
-
5Y
-
View Details
Overview
Ratios
Financials
Payouts
Performance
Sector
Analyst Ratings
New
Technicals
Holdings
Announcements
Insider Activity
Shariah
Profile
Highlights
Core annual income statement fields
Net sales
Gross profit
Operating profit
Profit before tax
Profit after tax
Income
Income statement
Balance
Balance sheet
Cash flow
Show growth %
Annual
Quarterly
Latest Results
Metrics
PKR(mn)
2023
2024
2025
2026
TTM
as of Jun-26
Net sales
1,810
3,659
5,837
9,461
9,460
Cost of sales
-1,360
-2,126
-3,550
-5,374
-5,374
Gross profit
450
1,533
2,288
4,088
4,086
Selling/distribution expenses
-137
-717
-1,445
-2,701
-2,702
Administrative expenses
-23
-40
-61
-202
-202
Operating profit
290
775
782
1,184
1,183
Depreciation & amortisation
35
37
194
275
275
EBITDA
325
812
975
1,459
1,459
Financial charges
-153
-151
-128
-106
-105
Other income
94
22
140
102
103
Other charges
-28
-64
-71
-113
-113
Profit before tax
203
582
724
1,067
1,067
Taxation
-53
-196
-277
-435
-435
Profit after tax
150
386
447
632
633
EPS - Basic
2.35
6.09
5.52
7.16
7.16
EPS - Diluted
2.35
6.09
5.52
7.16
7.16
